{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:58:13Z","timestamp":1777913893496,"version":"3.51.4"},"reference-count":28,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T00:00:00Z","timestamp":1384300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Toxicol Pathol"],"published-print":{"date-parts":[[2014,1]]},"abstract":"<jats:p>Pancreatic toxicity commonly affects the endocrine or exocrine pancreas. However, it can also occur at the endocrine\u2013exocrine interface (EEI), where the capillary network of the islet merges with the capillaries of the surrounding acinar tissue, that is, the insulo-acinar portal system. The goal of this article is to describe a novel, test article\u2013induced pancreatic toxicity that originated at the EEI and to summarize investigations into the mechanistic basis of the injury. This injury was initially characterized by light microscopy in 7\/14 day-toxicity studies in Sprague-Dawley (Crl: CD\u00ae[SD]) rats with undisclosed test articles. Microvascular injury at the interface resulted in peri-islet serum exudation, fibrin deposition, hemorrhage, inflammation, and secondary degeneration\/necrosis of surrounding exocrine tissue. More chronic injury presented as islet fibrosis and lobular atrophy. Direct cytotoxicity affecting the capillary endothelium at the EEI was confirmed ultrastructurally on day 4. Endothelial microparticle and blood flow studies further confirmed endothelial involvement. Similar lesions occurred less frequently in 2 other rat strains and not in the mouse, dog, or cynomolgus macaque. In summary, in vivo and investigative study data confirmed primary endothelial cytotoxicity in the pathogenesis of this lesion and suggested that the lesion may be rat\/rat strain\u2013specific and of uncertain relevance for human safety risk assessment.<\/jats:p>","DOI":"10.1177\/0192623313508851","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T23:29:02Z","timestamp":1384385342000},"page":"229-242","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":23,"title":["Mechanistic Investigations of Test Article\u2013Induced Pancreatic Toxicity at the Endocrine\u2013Exocrine Interface in the Rat"],"prefix":"10.1177","volume":"42","author":[{"given":"Karrie A.","family":"Brenneman","sequence":"first","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Andover, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashi K.","family":"Ramaiah","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Cambridge, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia M.","family":"Rohde","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Pearl River, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean M.","family":"Messing","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Andover, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn P.","family":"O\u2019Neil","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Andover, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren M.","family":"Gauthier","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Andover, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary S.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Andover, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasa R.","family":"Mantena","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Andover, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly M.","family":"Shevlin","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Andover, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Leonard","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Andover, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon A.","family":"Sokolowski","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Groton, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hungyun","family":"Lin","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Cambridge, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah C.","family":"Carraher","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Andover, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael I.","family":"Jesson","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Cambridge, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Cambridge, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutian","family":"Zhan","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Andover, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter F.","family":"Bobrowski","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Groton, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Bailey","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Andover, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Mark","family":"Vogel","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Cambridge, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale L.","family":"Morris","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Cambridge, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence O.","family":"Whiteley","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Cambridge, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"John W.","family":"Davis","sequence":"additional","affiliation":[{"name":"Pfizer, Worldwide Research & Development, Andover, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2013,11,13]]},"reference":[{"key":"bibr1-0192623313508851","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF02927066","volume":"12","author":"Bockman D. E.","year":"1992","journal-title":"Int J Pancreatol"},{"key":"bibr2-0192623313508851","first-page":"55","volume-title":"Toxicology of the Pancreas","author":"Bockman D. E.","year":"2005"},{"key":"bibr3-0192623313508851","doi-asserted-by":"publisher","DOI":"10.2337\/diab.31.10.883"},{"key":"bibr5-0192623313508851","unstructured":"Center for Drug Evaluation and Research (2011). Clinical pharmacology and biopharmaceutics review(s) (Application Number: 202439Orig1s000)."},{"key":"bibr7-0192623313508851","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4800(90)90066-M"},{"key":"bibr8-0192623313508851","doi-asserted-by":"publisher","DOI":"10.1177\/019262339402200107"},{"key":"bibr9-0192623313508851","first-page":"629","volume":"186","author":"Elayat A. A.","year":"1995","journal-title":"J Anat"},{"key":"bibr10-0192623313508851","first-page":"489","volume-title":"Histopathology of Preclinical Toxicity Studies: Interpretation and Relevance in Drug Safety Evaluation","author":"Greaves P.","year":"2012"},{"key":"bibr30-0192623313508851","unstructured":"GlaxoSmithKline (2011). Prescribing information, Myleran (busulfan) 2-mg scored tablets."},{"key":"bibr11-0192623313508851","first-page":"725","volume":"8","author":"Hayden M. R.","year":"2007","journal-title":"J Pancreas"},{"key":"bibr12-0192623313508851","doi-asserted-by":"publisher","DOI":"10.1111\/j.1559-4572.2008.00024.x"},{"key":"bibr13-0192623313508851","doi-asserted-by":"publisher","DOI":"10.1080\/01926230701230304"},{"key":"bibr14-0192623313508851","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1440169"},{"key":"bibr15-0192623313508851","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.8.2530"},{"key":"bibr16-0192623313508851","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1981.tb06909.x"},{"key":"bibr17-0192623313508851","volume":"34","author":"Kaduk B.","year":"1987","journal-title":"Hepato-gastroenterology"},{"key":"bibr18-0192623313508851","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051878"},{"key":"bibr19-0192623313508851","volume":"128","author":"Majno G.","year":"1987","journal-title":"Am J Pathol"},{"key":"bibr20-0192623313508851","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021617"},{"key":"bibr21-0192623313508851","volume":"55","author":"Murakami T.","year":"1992","journal-title":"Arch Histol Cytol"},{"key":"bibr23-0192623313508851","volume-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council","year":"2011","edition":"8"},{"key":"bibr24-0192623313508851","doi-asserted-by":"publisher","DOI":"10.1177\/0192623308318209"},{"key":"bibr25-0192623313508851","doi-asserted-by":"publisher","DOI":"10.1097\/00006676-199401000-00008"},{"key":"bibr31-0192623313508851","unstructured":"Otsuka America Pharmaceuticals (2011). Content of labeling, Busulfex (busulfan) Injection."},{"key":"bibr26-0192623313508851","doi-asserted-by":"publisher","DOI":"10.1210\/er.2009-0035"},{"key":"bibr27-0192623313508851","first-page":"144","volume":"155","author":"Sokolowski S.","year":"2011","journal-title":"CYTO2011"},{"key":"bibr28-0192623313508851","volume":"145","author":"Suschek C.","year":"1994","journal-title":"Am J Patho"},{"key":"bibr29-0192623313508851","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0029(19970601)37:5\/6<418::AID-JEMT6>3.0.CO;2-9"}],"container-title":["Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0192623313508851","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0192623313508851","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0192623313508851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:35:28Z","timestamp":1777653328000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0192623313508851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,13]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.1177\/0192623313508851"],"URL":"https:\/\/doi.org\/10.1177\/0192623313508851","relation":{},"ISSN":["0192-6233","1533-1601"],"issn-type":[{"value":"0192-6233","type":"print"},{"value":"1533-1601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,13]]}}}